| Literature DB >> 33299774 |
Sheeren Khaled1, Mohammad Almalki1, Ghada Shalaby1, Azmat K Niazi1, Sara Ahmed1, Asma Alsilami2, Mohannd Alhazmi2, Zeyad Bukhary2, Najeeb Jaha1.
Abstract
BACKGROUND: Epidemiological related differences in patients presenting with ST-elevation myocardial infarction (STEMI) have not yet been fully characterized in the Middle East countries. The aim of this study was to assess gender, ethnic and racial variation in clinical profiles, presentation and treatment strategies with relation to the in-hospital outcomes.Entities:
Keywords: Clinical profile; Epidemiology; In-hospital outcome; STEM
Year: 2020 PMID: 33299774 PMCID: PMC7721459 DOI: 10.37616/2212-5043.1139
Source DB: PubMed Journal: J Saudi Heart Assoc ISSN: 1016-7315
Fig. 1Distribution of AMI- Middle Eastern patients.
Fig. 2Distribution of AMI- Non- Arabic speaker patients.
Comparing baseline demographic, clinical, angiographic data and hospital outcomes of both genders.
| Variable | Male | Female | P value |
|---|---|---|---|
| N | N | ||
| I-Demographics and clinical data | |||
| Age (years) Mean ± SD | 55.35 ± 11.8 | 60.04 ± 11.2 | <0.001 |
| BMI (kg/m2) Mean ± SD | 27.86 ± 5.1 | 28.56 ± 5.6 | <0.001 |
| HBA1-C (mmol/mol) Mean ± SD | 7.54 ± 2.5 | 8.26 ± 4.2 | <0.001 |
| HB (g/dL) Mean ± SD | 14.14 ± 1.9 | 12.21 ± 1.9 | <0.001 |
| Glucose (mg/dL) Mean ± SD | 171.82 ± 76.2 | 191.17 ± 88.2 | 0.01 |
| Troponin 1st (ng/mL) Mean ± SD | 68.1 ± 181 | 69 ± 179 | NS |
| Troponin peak (ng/mL) Mean ± SD | 76.3 ± 136 | 120 ± 564 | NS |
| Serum Creatinine (mg/dL) Mean ± SD | 1.19 ± 1.1 | 1.13 ± 1.4 | NS |
| Pilgrims n,% | 800 (31%) | 224 (45%) | <0.001 |
| DM n,% | 1342 (52%) | 318 (64%) | <0.001 |
| HTN n,% | 1316 (51%) | 328 (66%) | <0.001 |
| Smoking n,% | 980 (38%) | 25 (5%) | <0.001 |
| DLP n,% | 361 (14%) | 77 (15%) | NS |
| Obesity (BMI >30 kg/m2) n,% | 696 (27%) | 179 (36%) | <0.001 |
| Valve problem n,% | 77 (3%) | 19 (4%) | NS |
| AF n,% | 20 (0.8%) | 19 (4%) | 0.002 |
| COPD n,% | 25 (1%) | 14 (3%) | NS |
| CVA n,% | 77 (3%) | 9 (2%) | NS |
| PVD n,% | 25 (1%) | 0 | NS |
| H/O IHD n,% | 516 (20%) | 99 (20%) | NS |
| OLD PCI/CABG n,% | 206 (8%) | 19 (4%) | 0.007 |
| STEMI | |||
| Anterior n,% | 1445 (56%) | 263 (53%) | NS |
| Inferior n,% | 1032 (40%) | 219 (44%) | |
| Other n,% | 104 (4%) | 16 (3%) | |
| Baseline LVEF% Mean ± SD | 40.78 ± 10.7 | 41.40 ± 10.6 | NS |
| LVT n,% | 232 (9%) | 44 (9%) | NS |
| Reperfusion strategies | |||
| Thrombolytic therapy n,% | 490 (19%) | 79 (16%) | NS |
| Non reperfusion (late presentation) n,% | 468 (18%) | 94 (19%) | NS |
| Emergency PCI (rescue PCI) n, % | 101 (4%) | 32 (6%) | NS |
| PPCI n,% | 1522 (59%) | 293 (59%) | NS |
| II- Angiographic data | |||
| Access site Radial n,% | 2038 (79%) | 338 (68%) | <0.001 |
| LM disease n,% | 77 (3%) | 14 (3%) | NS |
| MVD n,% | 412 (16%) | 79 (16%) | NS |
| DBT <90 min for PPCI n,% | 1187 (1522) (78%) | 212 (293) (72%) | NS |
| IRA | |||
| LAD n,% | 1419 (55%) | 268 (54%) | NS |
| LCX n,% | 154 (6%) | 29 (6%) | |
| RCA n,% | 851 (33%) | 159 (32%) | |
| PCI to LAD n,% | 1006 (39%) | 124 (25%) | NS |
| Tirofiban n,% | 645 (25%) | 109 (22%) | NS |
| Thrombus aspiration n,% | 335 (13%) | 59 (12%) | NS |
| III-Hospital outcome | |||
| Hospital death n,% | 69 (3%) | 23 (5%) | 0.027 |
| LOS (days) Mean ± SD | 5.64 ± 8.1 | 5.69 ± 7.1 | NS |
| Cardiac arrest n,% | 154 (6%) | 24 (5%) | NS |
| MV n,% | 129 (5%) | 29 (6%) | NS |
| LVEF <30% n,% | 567 (22%) | 114 (23%) | NS |
| Cardiogenic shock n,% | 129 (5%) | 14 (3%) | NS |
| Pulmonary edema n,% | 77 (3%) | 24 (5%) | 0.08 |
| Re admission n,% | 232 (9%) | 39 (8%) | NS |
| Repeated CAG n,% | 129 (5%) | 9 (2%) | NS |
| Major bleeding (HB drop> 3 gm) n,% | 129 (5%) | 19 (4%) | NS |
AF: Atrial Fibrillation; BMI: Body Mass Index; CABG: Coronary Artery Bypass Grafting; COPD: Chronic Obstructive Pulmonary Disease; CVA: Cerbro-Vascular Accidents; DBT: Door to Balloon Time; DLP: Dyslipidemia; DM: Diabetes Mellitus; HB: Hemoglobin; HBA1C: Glycosylated hemoglobin; IHD: Ischemic Heart Disease; IRA: Infarcted Related Artery; LAD: Left Anterior Descending Artery; LCX: Left Circumflex Artery; LVEF: Left Ventricular Ejection Fraction; LM: Left Main; LOS; Length of Stay; LVD: Left Ventricular Dysfunction; LVT: Left Ventricular Thrombus; MV; Mechanical Ventilation; MVD: Multi- Vessel Disease; PCI: Percutaneous Coronary Intervention; PPCI; Primary Percutaneous Coronary Intervention; PVD: Peripheral Vascular Disease; RCA: Right Coronary Artery.
Comparing baseline demographic, clinical, angiographic data and hospital outcomes of both ethnic groups.
| Variable | South Asian | Middle Eastern | P value |
|---|---|---|---|
| N | N | ||
| I-Demographics and clinical data | |||
| Age (years) Mean ± SD | 55.03 ± 11.1 | 56.57 ± 12.0 | 0.001 |
| Male gender n,% | 777 (85%) | 1804 (83%) | NS |
| BMI (kg/m2) Mean ± SD | 26.66 ± 4.4 | 28.31 ± 5.40 | <0.001 |
| HBA1-C (mmol/mol) Mean ± SD | 7.71 ± 2.4 | 7.64 ± 3.1 | NS |
| HB (g/dL) Mean ± SD | 13.84 ± 1.9 | 13.83 ± 2.04 | NS |
| Glucose (mg/dL) Mean ± SD | 180.98 ± 81.5 | 172.48 ± 77.4 | NS |
| Troponin 1st (ng/mL) Mean ± SD | 65.20 ± 171.1 | 68.22 ± 178.2 | NS |
| Troponin peak (ng/mL) Mean ± SD | 86.21 ± 126.2 | 118.12 ± 464.1 | NS |
| Serum Creatinine (mg/dL) Mean ± SD | 1.25 ± 1.3 | 1.26 ± 1.7 | NS |
| Pilgrims n,% | 503 (55%) | 521 (24%) | <0.001 |
| DM n,% | 445 (49%) | 1215 (56%) | 0.001 |
| HTN n,% | 463 (51%) | 1181 (54%) | 0.057 |
| Smoking n,% | 225 (25%) | 780 (36%) | <0.001 |
| DLP n,% | 128 (14%) | 310 (14%) | NS |
| Obesity (BMI >30) n,% | 169 (19%) | 706 (33%) | <0.001 |
| CVA n,% | 13 (1%) | 73 (3%) | <0.001 |
| IHD n,% | 143 (16%) | 472 (22%) | <0.001 |
| OLD PCI/CABG n,% | 41 (4%) | 184 (8%) | 0.001 |
| Anterior STEMI n,% | 501 (55%) | 1207 (56%) | NS |
| Baseline LVEF% Mean ± SD | 41.57 ± 10.9 | 41.16 ± 10.6 | NS |
| LVT n,% | 91 (10%) | 185 (9%) | NS |
| Reperfusion strategies | |||
| Thrombolytic therapy n,% | 143 (16%) | 426 (20%) | 0.019 |
| Non reperfusion (late presentation) n,% | 172 (19%) | 390 (18%) | NS |
| Emergency PCI (rescue) n,% | 59 (6%) | 74 (3%) | NS |
| PPCI n,% | 535 (59%) | 1280 (59%) | NS |
| II- Angiographic data | |||
| Access site | |||
| Radial n,% | 683 (75%) | 1693 (78%) | NS |
| LM disease n,% | 32 (4%) | 59 (3%) | NS |
| MVD n,% | 159 (17%) | 332 (15%) | NS |
| DBT <90 min of PPCI n,% | 418 (535) (78%) | 954 (1280) (75%) | NS |
| Tirofiban n,% | 235 (26%) | 519 (24%) | NS |
| Thrombus aspiration n,% | 118 (13%) | 276 (13%) | NS |
| III-Hospital outcome | |||
| Thrombus aspiration n,% | 111 (12%) | 283 (13%) | NS |
| Hospital death n,% | 27 (3%) | 65 (3%) | NS |
| LOS (days) Mean ± SD | 5.59 ± 7.34 | 5.68 ± 8.12 | NS |
| Cardiac arrest n,% | 59 (6%) | 119 (5%) | NS |
| MV n,% | 59 (6%) | 99 (4%) | NS |
| Cardiogenic shock n,% | 49 (5%) | 94 (4%) | NS |
| Pulmonary edema n,% | 41 (5%) | 60 (3%) | 0.012 |
| LVD (LVEF<30%) n,% | 215 (24%) | 466 (21%) | NS |
| Major bleeding (HB drop> 3 gm) n,% | 49 (5%) | 99 (4%) | NS |
BMI: Body Mass Index; CABG: Coronary Artery Bypass Grafting; CVA: Cerebrovascular Accidents; DBT; Door to Balloon Time; DLP: Dyslipidemia; DM: Diabetes Mellitus; HB: Hemoglobin; HBA1C: Glycosylated hemoglobin; IHD: Ischemic Heart Disease; LM: Left Main; LOS; Length of Stay; LVD: Left Ventricular Dysfunction; LVEF: Left Ventricular Ejection Fraction; LVT: Left Ventricular Thrombus; MVD: Multi-Vessel Disease; MV; Mechanical Ventilation; PCI: Percutaneous Coronary Intervention; PPCI: Primary Percutaneous Coronary Intervention.
Baseline demographic, clinical data and hospital outcomes of both Arabic and non-Arabic speakers.
| Variables | Non Arabic speakers | Arabic speakers | P-value |
|---|---|---|---|
| N | N | ||
| I-Clinical data | |||
| Age (years) Mean ± SD | 55.25 ± 10.8 | 55.23 ± 10.7 | NS |
| Male gender n,% | 984 (82%) | 1597 (85%) | 0.032 |
| DM n,% | 576 (48%) | 1084 (58%) | <0.001 |
| Smoking n,% | 300 (25%) | 705 (38%) | <0.001 |
| HTN n,% | 624 (52%) | 1020 (54%) | NS |
| Obesity (BMI >30 kg/m2) n,% | 213 (19%) | 644 (34%) | <0.001 |
| CVA n,% | 17 (1%) | 69 (4%) | 0.001 |
| Dyslipidemia n,% | 162 (14%) | 276 (15%) | NS |
| IHD n,% | 231 (19%) | 384 (20%) | NS |
| OLD PCI/CABG n,% | 88 (7%) | 137 (7%) | NS |
| Anterior STEMI n,% | 672 (56%) | 1036 (55%) | NS |
| Reperfusion strategies | |||
| Thrombolytic therapy n,% | 149 (12%) | 420 (22%) | <0.001 |
| Non reperfusion (late presentation) n,% | 306 (26%) | 256 (14%) | <0.001 |
| Emergency PCI (rescue) n,% | 48 (4%) | 85 (5%) | NS |
| PPCI n,% | 697 (58%) | 1118 (59%) | NS |
| II- Angiographic data | |||
| Access site | |||
| Radial n,% | 911 (76%) | 1465 (78%) | NS |
| LM disease n,% | 44 (4%) | 47 (3%) | NS |
| MVD n,% | 216 (18%) | 275 (15%) | NS |
| DBT <90 min of PPCI n,% | 541 (697) (78%) | 831 (1118) (74%) | NS |
| Tirofiban n,% | 303 (25%) | 456 (24%) | NS |
| Thrombus aspiration n,% | 143 (12%) | 251 (13%) | NS |
| III-Hospital outcome | |||
| Pulmonary Edema n,% | 36 (3%) | 65 (3%) | NS |
| Cardiogenic Shock n,% | 56 (5%) | 87 (5%) | NS |
| MV n,% | 77 (6%) | 81 (4%) | 0.002 |
| Cardiac Arrest n,% | 56 (5%) | 122 (5%) | NS |
| In-hospital Death n,% | 30 (3%) | 62 (3%) | NS |
BMI: Body Mass Index; CABG: Coronary Artery Bypass Grafting; CVA: Cerebrovascular Accidents; DM: Diabetes Mellitus; HTN: Hypertension; IHD: Ischemic Heart Disease; MV; Mechanical Ventilation; PCI: Percutaneous Coronary Intervention; STEMI: ST-Elevation Myocardial Infarction.
Binary regression analysis for prediction of mortality.
| Variable | B | S.E. | EXP (B) | P value |
|---|---|---|---|---|
| Age (years) | 0.046 | 0.019 | 1.047 | 0.013 |
| MVD | 0.899 | 0.455 | 0.407 | 0.048 |
| LVD (LVEF<30%) | 1.719 | 0.435 | 0.179 | <0.0001 |
LVEF: Left Ventricular Ejection Fraction; LVD: Left Ventricular Dysfunction; MVD: Multi-Vessel Disease.